News
Issue #2001 - 26 (June 2001)
(Updated June 27,  2001)

APPLICATIONS 

Glaxosmithkline, Numoda Partner on Wireless Clinical Study

It was announced today that GlaxoSmithKline (GSK) has signed a contract with Numoda Corporation to deploy Numoda mTrial™ handheld software on Symbol® Devices to automate patient screening and data collection for an upcoming GSK clinical study.

The patented Numoda mTrial and wireless client server technology facilitates the screening and dosing of patients, and helps GSK solve a significant logistics challenge. The Numoda mTrial mobile application replaces a paper process used in previous trials.

"Numoda is excited to be paired with a company who understands innovation within the pharmaceutical industry and the value of our wireless expertise," said Mary Schaheen, President and CEO, Numoda Corporation.

GSK selected Numoda because they are the only third-party validated wireless company that enables automatic, direct data-entry at the point of care, and simultaneous transmission of that data to a central server from several disparate locations. These data will be instantly analyzed for the project manager and transmitted back to the trial sites via Numoda's bi-directional wireless synchronization for real-time decision-making.

For more information: http://www.numoda.com/pages/GlaxoSmithKline%20Signs%20Contract%20with%20Numoda.htm

Mobileinfo Comments and Advisory: An interesting and useful handheld application in healthcare field where need for productivity improvements is high. Numoda has several software applications for mobile data capture. 

Note: This news release may contain forward-looking statements. Readers should take appropriate caution in developing plans utilizing these products, services and technology architectures.  All trademarks used in this summary are the property of their respective owners.